Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

F. Bray; J. Ferlay; I. Soerjomataram; R. Siegel; L. Torre; A. Jemal

DOI:10.3322/caac.21492

Corpus ID: 52188256

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

@article{Bray2018GlobalCS,
  title={Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries},
  author={F. Bray and J. Ferlay and I. Soerjomataram and R. Siegel and L. Torre and A. Jemal},
  journal={CA: A Cancer Journal for Clinicians},
  year={2018},
  volume={68}
}

F. Bray, J. Ferlay, +3 authors A. Jemal

Published 2018

Medicine

CA: A Cancer Journal for Clinicians

This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. [...] Key Result In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6…Expand Abstract

View on Wiley

Share This Paper

Top 3 of 16,856 Citations

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Rui-Mei Feng, Yi-Nan Zong, … R. XuCancer communications2019

163

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

J. Ferlay, M. Colombet, … F. BrayInternational journal of cancer2019

1084

Global trends in colorectal cancer mortality: projections to the year 2035

M. Araghi, I. Soerjomataram, … M. ArnoldInternational journal of cancer2019

Paper Mentions

INTERVENTIONAL CLINICAL TRIAL

Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer

In this study, patients who are going to undergo endoscopic submucosal dissection (ESD) or surgery for early gastric cancer will be enrolled and divided into ESD group and Surgery… Expand

Conditions	Early Gastric Cancer
Intervention	Procedure

Peking University Third Hospital

March 2019 - December 2029

INTERVENTIONAL CLINICAL TRIAL

Determination of Microbiological Factors Predicting Poor Response to Neoadjuvant Treatment in Rectal Cancers

The objective of this project is to determine in a non-invasive manner (fecal samples) the predictive value of the intestinal microbiota and the presence of genotoxin-producing… Expand

Conditions	Rectal Cancer
Intervention	Other

Institut du Cancer de Montpellier - Val d'Aurelle

November 2019 - November 2027

INTERVENTIONAL CLINICAL TRIAL

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiation Therapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

Multimodal treatment combining surgery with chemotherapy and/or radiotherapy is necessary to improve the chances of survival in patients with locally advanced thoracic esophageal cancer… Expand

Conditions	Esophageal Squamous Cell Carcinoma
Intervention	Drug, Radiation

Henan Cancer Hospital

October 2019 - October 2027

INTERVENTIONAL CLINICAL TRIAL

Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery

Pancreatic cancer remains a devastating disease with an average 5-year survival rate of about 3-5%. Previous retrospective studies showed that perioperative epidural block and/or… Expand